rhTPO increases nadir platelet count.

In patients undergoing intensive chemotherapy for gynecologic malignancy, rhTPO (given on days 2, 4, 6, and 8 after chemotherapy) increased the nadir platelet count. The platelet nadir also occurred earlier in patients treated with rhTPO than in untreated patients. Figure provided by Pharmacia (Peapack, NJ) from data in study by Vadhan-Raj et al.104